Design, synthesis, and antitumor activity evaluation of carbazole derivatives with potent HDAC inhibitory activity

Histone deacetylase (HDAC), a key regulator in controlling the acetylation status of histone, are considered to be associated with viability, migration, invasion, proliferation and apoptosis of malignant tumors. The HDAC inhibition is an effective strategy for designing compounds against malignant t...

Full description

Saved in:
Bibliographic Details
Published inMedicinal chemistry research Vol. 32; no. 8; pp. 1677 - 1689
Main Authors Sun, Likun, Han, Leiqiang, Zhang, Liang, Chen, Chen, Zheng, Chengyun
Format Journal Article
LanguageEnglish
Published New York Springer US 01.08.2023
Springer Nature B.V
Subjects
Acetylation
Anticancer properties
Antitumor activity
Antitumor agents
Apoptosis
Biochemistry
Biomedical and Life Sciences
Biomedicine
Bioorganic Chemistry
Carbazole
Carbazoles
Caspase-3
Flow cytometry
Histone deacetylase
Histones
Inorganic Chemistry
Medicinal Chemistry
Optimization
Original Article
Pharmacology/Toxicology
Tumor cells
Tumors
HDAC inhibitory
Carbazole
Antitumor
Apoptosis
Online AccessGet full text

Cover

More Information
Summary:Histone deacetylase (HDAC), a key regulator in controlling the acetylation status of histone, are considered to be associated with viability, migration, invasion, proliferation and apoptosis of malignant tumors. The HDAC inhibition is an effective strategy for designing compounds against malignant tumors and five compounds have been approved by FDA or NMPA for clinical therapy. In this study, we designed and synthesized a series of novel carbazole-hydroxamate analogues as HDAC inhibitors and evaluated their anti-tumor properties in vitro. Compared with vorinostat, the HDAC semi-inhibitory concentration of compounds 3f and 3g decreased 4–13 folds, compounds 8a and 8c also showed strong inhibitory HDAC activity, and compound 3g had a strong inhibitory effect on HDAC 1. The CCK8 assay showed that compounds 3g displayed good antiproliferative activity on tested tumor cells. Flow cytometric and western blot assay showed that 3g exerted anti-tumor activities by regulating the level of Ac-HH3 and activating the cleaved caspase 3. Based on these results, carbazole-hydroxamate derivative 3g might become a potential anti-tumor candidate molecule to further structural optimization research. Graphical Abstract
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:1054-2523
1554-8120
DOI:10.1007/s00044-023-03084-0